AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10522614
Drug: Interferon-alpha-2b and
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha-2b and ribavirin (combination therapy)
Trial: 30735073
Drug: DHA (3
RxNorm normalized name: Gesticare DHA (30) Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA (3 g/day)
Trial: 20817132
Drug: Transdermal nitroglycerin
RxNorm normalized name: nitroglycerin Transdermal System
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal nitroglycerin (GTN)
Trial: 10904464
Drug: Warfarin sodium
RxNorm normalized name: Warfarin Sodium
DrugBank: Warfarin (DB00682)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Warfarin sodium (postoperative)
Trial: 20683147
Drug: Elevated CRP
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elevated CRP (top 15 percentile; CRP >= 2.09 mg/L)
Trial: 25899750
Drug: Dopaminergic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopaminergic treatment (ON state)
Trial: 16787687
Drug: docetaxel 75
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: docetaxel 75 mg/m2 plus cisplatin 75 mg/m2, every 3 weeks (DC)
Trial: 31996370
Drug: PSA ≤
RxNorm normalized name: Prostate-Specific Antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PSA ≤ 1 ng/mL, black men
Trial: 12955634
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg levofloxacin per day for 10 days
Trial: 6351957
Drug: sulphamethoxazole 1000
RxNorm normalized name: Sulphamethoxazole
DrugBank: Sulfamethoxazole (DB01015)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sulphamethoxazole 1000 mg twice daily for 7 days
Trial: 11749745
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment group
Trial: 17127550
Drug: GABA medications
RxNorm normalized name: GABA
DrugBank: gamma-Aminobutyric acid (DB02530)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GABA medications
Trial: 9505990
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of butorphanol nasal spray (1 mg) and metoclopramide (10 mg)
Trial: 16247099
Drug: North American
RxNorm normalized name: North American coral snake antivenin
DrugBank: Coral snake (micrurus fulvius) immune globulin antivenin (equine) (DB13883)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: North American ginseng extract (2 capsules per day for 4 months)
Trial: 7582391
Drug: Mebhydroline (Omeril)
RxNorm normalized name: mebhydroline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mebhydroline (Omeril) 100 mg t.i.d.
Trial: 27776458
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (recommended sports brassiere, refraining from caffeine and methylxanthine-containing foods, and simple analgesics)
Trial: 29549829
Drug: Dexmedetomidine 1
RxNorm normalized name: DEXMEDETOMIDINE 120MCG SUBLINGUAL FILM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 1 μg/kg bolus followed by 0.2-0.7 μg/kg/h infusion from induction of anesthesia to the end of surgery (group D1)
Trial: 29549829
Drug: Dexmedetomidine 1
RxNorm normalized name: DEXMEDETOMIDINE 120MCG SUBLINGUAL FILM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 1 μg/kg bolus (group D2)
Trial: 29601443
Drug: Digital Rectal
RxNorm normalized name: BD Thermometer Digital Rectal (obsolete)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digital Rectal Examination (DRE)
Trial: 2655367
Drug: Measurement of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Measurement of local anaesthetic agent removed from the isolated arm after 15 min
Trial: 10577447
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg candoxatril twice a day
Trial: 31608389
Drug: Internet-delivered cognitive
RxNorm normalized name: DELIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-delivered cognitive therapy (CT)
Trial: 10598693
Drug: Timolol (TIMOPTIC)
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol (TIMOPTIC) twice daily
Trial: 10598693
Drug: Dorzolamide (TRUSOPT)
RxNorm normalized name: dorzolamide Ophthalmic Solution [Trusopt]
DrugBank: Dorzolamide (DB00869)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dorzolamide (TRUSOPT) three times daily
Trial: 7623395
Drug: Cognitive-behavioral group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral group program with nicotine patches
Trial: 21435408
Drug: HIV vaccine
RxNorm normalized name: AAV-2 HIV Vaccine
DrugBank: TGAAC09 (DB06363)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIV vaccine (RV144)
Trial: 12586132
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH; 7500 anti-Xa U twice a day subcutaneous)
Trial: 2709521
Drug: Polytetrafluoroethylene patch
RxNorm normalized name: polytetrafluoroethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polytetrafluoroethylene patch closure
Trial: 12772814
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy followed by local‐regional radiotherapy
Trial: 29563377
Drug: Heparin (bolus)
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Heparin (bolus)
Trial: 24237691
Drug: Yohimbine HCl
RxNorm normalized name: yohimbine HCl
DrugBank: Yohimbine (DB01392)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine HCl (10.8 mg)
Trial: 18568228
Drug: Chemical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemical treatment
Trial: 19474053
Drug: Nifedipine GITS
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine GITS 30-60 mg/day
Trial: 15327583
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of Alpha-lipoic acid (ALA)
Trial: 28492711
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy with curcumin
Trial: 17203353
Drug: Serenoa repens
RxNorm normalized name: Serenoa Repens Fruit
DrugBank: Saw palmetto (DB14360)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serenoa repens (SR) 320 mg per day
Trial: 17203353
Drug: Tamsulosin (TAM)
DrugBank: Tamsulosin (DB00706)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tamsulosin (TAM) 0.4 mg per day
Trial: 12851511
Drug: Transdermal hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal hormone replacement therapy (50 microg daily of 17beta-estradiol plus 10 mg dydrogesterone daily for 14 days of each 28-day cycle)
Trial: 10541423
Drug: Fexofenadine HCl
RxNorm normalized name: fexofenadine HCl
DrugBank: Fexofenadine (DB00950)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fexofenadine HCl 120 mg QD
Trial: 2455170
Drug: Low-dose clonidine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose clonidine (0.075 mg per day)
Trial: 19526040
Drug: No therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No therapy (Control)
Trial: 30258217
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of two potent bNAbs (3BNC117 and 10-1074) administered at 30 mg kg-1 each
Trial: 29403482
Drug: Pentavalent rotavirus
RxNorm normalized name: Vaccine product containing only live pentavalent Rotavirus antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentavalent rotavirus vaccine (RV5)
Trial: 16943400
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg celecoxib twice daily
Trial: 16943400
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg celecoxib twice daily
Trial: 15994623
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive (ethinyl estradiol 20 microg and levonorgestrel 100 microg)
Trial: 17389559
Drug: Oral contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptive
Trial: 1389195
Drug: Blind oral
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blind oral intubation without the use of a laryngoscope (Group 2)
Trial: 21936907
Drug: Restrictive red
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Restrictive red cell transfusion strategy (target hemoglobin of 70‐90 g/L)
Trial: 21936907
Drug: Liberal red
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liberal red cell transfusion strategy (target hemoglobin of 90‐110 g/L)
Trial: 16467715
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg twice daily
Trial: 22136963
Drug: Intravenous lipid
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous lipid emulsion containing eicosapentaenoic and docosahexaenoic acid
Trial: 20617588
Drug: Prednisolone tablets
RxNorm normalized name: Prednisolone Tablets
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone tablets 1 mg/(kg x d), 2 times/d for 2 weeks, then gradually reducing; all-trans retinoic acid 10 mg, 3 times a day, oral
Trial: 7799476
Drug: Sodium citrate
RxNorm normalized name: Sodium Citrate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium citrate (0.5 g kg‐1 body mass)
Trial: 16461202
Drug: Indapamide SR
RxNorm normalized name: Indapamide
DrugBank: Indapamide (DB00808)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Indapamide SR (1.5 mg)
Trial: 2455104
Drug: Pindolol 10
RxNorm normalized name: pindolol 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol 10 mg per day
Trial: 11642629
Drug: 9-valent conjugate
RxNorm normalized name: L1 protein, human papillomavirus type 31 vaccine
DrugBank: Human papillomavirus type 31 L1 capsid protein antigen (DB10310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9-valent conjugate pneumococcal vaccine (conjugated to CRM197)
Trial: 8751020
Drug: Intramuscular atropine
RxNorm normalized name: Atropine
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular atropine (0.02 mg/kg)
Trial: 26417901
Drug: Sublingual liquid
RxNorm normalized name: B Complex with B-12 Sublingual Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual liquid birch pollen preparation (SB) 10,000 AUN/ml
Trial: 26417901
Drug: Sublingual liquid
RxNorm normalized name: B Complex with B-12 Sublingual Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual liquid birch pollen preparation (SB) 20,000 AUN/ml
Trial: 26417901
Drug: Sublingual liquid
RxNorm normalized name: B Complex with B-12 Sublingual Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual liquid birch pollen preparation (SB) 40,000 AUN/ml
Trial: 31226322
Drug: Tamoxifen 10mg
RxNorm normalized name: TAMOXIFEN 10MG/5ML SOLN,ORAL
DrugBank: Tamoxifen (DB00675)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tamoxifen 10mg twice daily for 7 days starting 21 days after IUS insertion
Trial: 22112008
Drug: Pro-recovery intervention
RxNorm normalized name: nioxin PRO CLINICAL SCALP RECOVERY KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pro-recovery intervention (treatment as usual plus recovery-promoting relationships and working practices)
Trial: 10663897
Drug: Biofeedback treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biofeedback treatment for patients with rectocele (Group 1)
Trial: 10520842
Drug: Oral hyoscyamine
RxNorm normalized name: hyoscyamine Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hyoscyamine (0.25 mg)
Trial: 16047027
Drug: Arginine supplementation
RxNorm normalized name: Arginine
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Arginine supplementation (15 g/day for 4 weeks after pneumococcal vaccine)
Trial: 10447220
Drug: Lifibrol therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lifibrol therapy
Trial: 22268365
Drug: Irbesartan 300
RxNorm normalized name: irbesartan 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan 300 mg
Trial: 29547978
Drug: Stimulant medication
RxNorm normalized name: Staphylococcus simulans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulant medication ON
Trial: 29547978
Drug: Stimulant medication
RxNorm normalized name: Staphylococcus simulans
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stimulant medication OFF
Trial: 24200934
Drug: Chlorella supplementation
RxNorm normalized name: Chlorella emersonii extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorella supplementation (8 g Chlorella/day/person; equivalent to 22.9 mg lutein/day/person)
Trial: 17138156
Drug: Epinephrine infusion
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine infusion at 50 ng/kg per minute under sedation with nitrous oxide (30% inhalation)
Trial: 17022854
Drug: IV dipyrone
RxNorm normalized name: dipyrone
DrugBank: Metamizole (DB04817)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV dipyrone 1 g
Trial: 28479175
Drug: PCV13 without
RxNorm normalized name: Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine
DrugBank: Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria CRM197 protein conjugate antigen (DB10289)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCV13 without 2-phenoxyethanol in single-dose syringe (SDS)
Trial: 25640577
Drug: Extracorporeal shockwave
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shockwave therapy (1000 impulses)
Trial: 16478902
Drug: Tetracaine plus
RxNorm normalized name: Tetracaine
DrugBank: Tetracaine (DB09085)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tetracaine plus Morphine
Trial: 30102493
Drug: One dose
RxNorm normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: One dose of measles vaccine
Trial: 14974944
Drug: EC-MPS 720
RxNorm normalized name: 6 MP
DrugBank: Mercaptopurine (DB01033)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EC-MPS 720 mg b.i.d.
Trial: 10774861
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml 0.5% bupivacaine without corticosteroid
Trial: 27895406
Drug: Simplified dyad
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simplified dyad criteria (combination of proliferation and VS)
Trial: 25814381
Drug: Medication-assisted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication-assisted therapy (buprenorphine or methadone)
Trial: 23870611
Drug: Sarpogrelate CR
RxNorm normalized name: Sarpogrelate
DrugBank: Sarpogrelate (DB12163)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarpogrelate CR 300 mg administered in the fasted condition
Trial: 23870611
Drug: Sarpogrelate CR
RxNorm normalized name: Sarpogrelate
DrugBank: Sarpogrelate (DB12163)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarpogrelate CR 300 mg administered after a high-fat breakfast
Trial: 9866000
Drug: Vaginal gemeprost
RxNorm normalized name: gemeprost
DrugBank: Gemeprost (DB08964)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal gemeprost (1 mg every 3 h for a maximum of five doses in 24 h)
Trial: 8270987
Drug: Mitomycin (MIT‐C)
RxNorm normalized name: Mitomycin
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin (MIT‐C) 40 mg
Trial: 8645625
Drug: Droloxifene 40
RxNorm normalized name: Droloxifene
DrugBank: Droloxifene (DB15641)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droloxifene 40 mg o.d. (group 1)
Trial: 19391153
Drug: Therapist flexibility
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapist flexibility in cognitive-behavioral therapy
Trial: 15464489
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no prostacyclin treatment)
Trial: 7608311
Drug: Isradipine-CR 5
RxNorm normalized name: isradipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine-CR 5 mg
Trial: 7608311
Drug: Isradipine-CR 10
RxNorm normalized name: isradipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine-CR 10 mg
Trial: 7608311
Drug: Isradipine-CR 20
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isradipine-CR 20 mg
Trial: 25516380
Drug: Lamotrigine therapy
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine therapy
Trial: 19474264
Drug: Tetanus toxoid
RxNorm normalized name: Tetanus Toxoid
DrugBank: Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tetanus toxoid vaccine
Trial: 26309227
Drug: Intravenous methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous methylprednisolone during radiotherapy for 14 days
Trial: 7525038
Drug: Pamidronate 60
RxNorm normalized name: pamidronate 60 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pamidronate 60 mg every 2 weeks
Trial: 23593253
Drug: Ty21a vaccine
RxNorm normalized name: Typhoid Vaccine Live Ty21a
DrugBank: Typhoid Vaccine Live (DB11050)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ty21a vaccine
Trial: 2882626
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 1.5 g/day
Trial: 8033939
Drug: Antiplatelet medication
RxNorm normalized name: simethicone
DrugBank: Simethicone (DB09512)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiplatelet medication
Trial: 8145910
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IVIg) 0.4 g/kg body weight per day for 5 consecutive days
Trial: 8602598
Drug: Gum arabic
RxNorm normalized name: Gum arabic
DrugBank: Acacia (DB10451)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gum arabic (50 g/d)
Trial: 19695030
Drug: Olmesartan 40
RxNorm normalized name: HCTZ 25/OLMESARTAN 40MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan 40 mg administered at bedtime
Trial: 16495014
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT), 4 sessions
Trial: 23337270
Drug: Ankle block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ankle block administered after inflation of tourniquet (Group A)
Trial: 10827332
Drug: Norplant(R) contraceptive
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norplant(R) contraceptive implants
Trial: 25963064
Drug: Beta Blocker
RxNorm normalized name: Beta blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta Blocker Therapy
Trial: 1974070
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg lorazepam
Trial: 12424549
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg lorazepam
Trial: 22273498
Drug: 800-nm diode
RxNorm normalized name: NM-004
DrugBank: NM-004 (DB18066)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800-nm diode laser treatment
Trial: 31067358
Drug: High-dose interferon-α
RxNorm normalized name: interferon-beta
DrugBank: Human interferon beta (DB14999)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose interferon-α (HDI)
Trial: 22196464
Drug: Transfusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transfusion of a fixed dose of 12 ml/kg of FFP
Trial: 31508999
Drug: Mechanical bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mechanical bowel preparation plus oral antibiotic bowel preparation (neomycin and metronidazole)
Trial: 29112565
Drug: Mechanical bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mechanical bowel preparation
Trial: 3297375
Drug: Sublingual lorazepam
RxNorm normalized name: Lorazepam
DrugBank: Lorazepam (DB00186)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual lorazepam combined with high-dose metoclopramide (3 mg/kg) infused twice 3 h apart with i.v. dexamethasone